ArticleBritish journal of haematology2024

Exposure to obinutuzumab does not affect outcomes of SARS-CoV-2 infection in vaccinated patients with newly diagnosed advanced-stage follicular lymphoma.

A Pinto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.